We are live on ! Find out more
KKRC

Kohlberg Kravis Roberts & Co Portfolio holdings

AUM $5.71B
1-Year Est. Return 72.37%
This Fund
S&P 500
This Quarter Est. Return
+9.27%
1 Year Est. Return
+72.37%
3 Year Est. Return
+314.1%
5 Year Est. Return
+269.97%
10 Year Est. Return
+1,085.75%
AUM
$8.06B
AUM Growth
-$1.44B
Cap. Flow
-$1.97B
Cap. Flow %
-24.42%
Top 10 Hldgs %
90.93%
Holding
65
New
11
Increased
1
Reduced
6
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 54.18%
2 Consumer Staples 24.42%
3 Technology 9.34%
4 Miscellaneous 6.5%
5 Industrials 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE.PRP
51
DELISTED
NEXTERA ENERGY INC EQUITY UNIT
NEE.PRP
-1,736,255
Closed -$116M

Similar funds

Kohlberg Kravis Roberts & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Kohlberg Kravis Roberts & Co held 65 positions worth $8.06B, down 15% from $9.49B the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Kohlberg Kravis Roberts & Co withdrew a net $1.97B in Q3 2016, closing 9 positions and reducing 6 holdings. Its most notable exit was Zimmer Biomet, an estimated $453M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 60% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Kohlberg Kravis Roberts & Co opened a new position in Crown Castle International Corp. worth $219M.

  • Kohlberg Kravis Roberts & Co's largest Q3 2016 buy was Crown Castle International Corp.: 1,941,459 shares worth $219M.
  • Kohlberg Kravis Roberts & Co's biggest Q3 2016 reduction was Walgreens Boots Alliance, cutting an estimated $1.19B.
  • Kohlberg Kravis Roberts & Co fully exited Zimmer Biomet in Q3 2016, selling an estimated $453M.
  • Kohlberg Kravis Roberts & Co's ten largest holdings make up 91% of its $8.06B portfolio in Q3 2016.
  • Kohlberg Kravis Roberts & Co opened 11 new positions and closed 9 in Q3 2016.
  • Kohlberg Kravis Roberts & Co's portfolio value fell 15% quarter-over-quarter to $8.06B.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2016, filed 14 Nov 2016.